Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 2
2021 16
2022 13
2023 5
2024 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

31 results

Results by year

Filters applied: . Clear all
Page 1
COVID-19 vaccines: what do we know so far?
Dhillon P, Altmann D, Male V. Dhillon P, et al. FEBS J. 2021 Sep;288(17):4996-5009. doi: 10.1111/febs.16094. Epub 2021 Jul 19. FEBS J. 2021. PMID: 34288409 Free PMC article.
Adaptive immunity to SARS-CoV-2.
Altmann DM. Altmann DM. Oxf Open Immunol. 2020;1(1):iqaa003. doi: 10.1093/oxfimm/iqaa003. Epub 2020 Jul 9. Oxf Open Immunol. 2020. PMID: 34192266 Free PMC article. Review.
Serum biomarkers associated with SARS-CoV-2 severity.
de Morais Batista F, Puga MAM, da Silva PV, Oliveira R, Dos Santos PCP, da Silva BO, Tatara MB, Tsuha DH, Dos Santos Pires MA, Gonçalves CCM, Pessoa E Silva R, Ferreira NT, de Barros Albuquerque AP, da Silva Duarte G, Consolaro MEL, Negrão FJ, Ferrari IC, de Goes Cavalcanti LP, Trinta KS, Ribeiro GS, de Melo Rêgo MJB, Boyton RJ, Siqueira AM, Altmann DM, Croda J. de Morais Batista F, et al. Sci Rep. 2022 Sep 26;12(1):15999. doi: 10.1038/s41598-022-20062-5. Sci Rep. 2022. PMID: 36163447 Free PMC article.
Pre-existing polymerase-specific T cells expand in abortive seronegative SARS-CoV-2.
Swadling L, Diniz MO, Schmidt NM, Amin OE, Chandran A, Shaw E, Pade C, Gibbons JM, Le Bert N, Tan AT, Jeffery-Smith A, Tan CCS, Tham CYL, Kucykowicz S, Aidoo-Micah G, Rosenheim J, Davies J, Johnson M, Jensen MP, Joy G, McCoy LE, Valdes AM, Chain BM, Goldblatt D, Altmann DM, Boyton RJ, Manisty C, Treibel TA, Moon JC; COVIDsortium Investigators; van Dorp L, Balloux F, McKnight Á, Noursadeghi M, Bertoletti A, Maini MK. Swadling L, et al. Nature. 2022 Jan;601(7891):110-117. doi: 10.1038/s41586-021-04186-8. Epub 2021 Nov 10. Nature. 2022. PMID: 34758478 Free PMC article.
Neutralising antibody potency against SARS-CoV-2 wild-type and omicron BA.1 and BA.4/5 variants in patients with inflammatory bowel disease treated with infliximab and vedolizumab after three doses of COVID-19 vaccine (CLARITY IBD): an analysis of a prospective multicentre cohort study.
Liu Z, Le K, Zhou X, Alexander JL, Lin S, Bewshea C, Chanchlani N, Nice R, McDonald TJ, Lamb CA, Sebastian S, Kok K, Lees CW, Hart AL, Pollok RC, Boyton RJ, Altmann DM, Pollock KM, Goodhand JR, Kennedy NA, Ahmad T, Powell N; CLARITY study investigators. Liu Z, et al. Lancet Gastroenterol Hepatol. 2023 Feb;8(2):145-156. doi: 10.1016/S2468-1253(22)00389-2. Epub 2022 Dec 5. Lancet Gastroenterol Hepatol. 2023. PMID: 36481043 Free PMC article.
Imprinted hybrid immunity against XBB reinfection.
Boyton RJ, Altmann DM. Boyton RJ, et al. Lancet Infect Dis. 2023 Jul;23(7):764-765. doi: 10.1016/S1473-3099(23)00138-X. Epub 2023 Mar 13. Lancet Infect Dis. 2023. PMID: 36924785 Free PMC article. No abstract available.
Decoding the unknowns in long covid.
Altmann DM, Boyton RJ. Altmann DM, et al. BMJ. 2021 Feb 4;372:n132. doi: 10.1136/bmj.n132. BMJ. 2021. PMID: 33541867 No abstract available.
Immunity to SARS-CoV-2 variants of concern.
Altmann DM, Boyton RJ, Beale R. Altmann DM, et al. Science. 2021 Mar 12;371(6534):1103-1104. doi: 10.1126/science.abg7404. Science. 2021. PMID: 33707254 No abstract available.
31 results